Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study (Q35085084)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study
scientific article

    Statements

    Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study (English)
    Daniel Palmer
    Richard Jackson
    Paula Ghaneh
    Charlotte L Rawcliffe
    Deborah D Stocken
    Derek O'Reilly
    David Goldstein
    Christos Karapetis
    Andrew Scarfe
    Francois Lacaine
    Juhani Sand
    Jakob R Izbicki
    Attila Oláh
    Giovanni Butturini
    Pehr A Lind
    Mark R Middleton
    Alan Anthoney
    Kate Sumpter
    Ross Carter
    13 January 2014

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit